Dr. Jacob A. Sands shares how antibody-drug conjugates, such as Datroway, work to selectively target and destroy tumor cells among those with lung cancer. Antibody-drug conjugates like Datroway ...

If you missed NewsNation’s “Killing Cancer: The Power Within” special report, you can see an encore presentation on Thursday at 9p/8C. Click here to find NewsNation in your lineup. (NewsNation) — ...

Tumours have developed many strategies and tricks to gain advantages in the body. Led by cell biology professor Sabine Werner, researchers at ETH Zurich have now discovered another surprising trick ...

Senescent fibroblasts are aging cells in connective tissue that no longer divide and protect against tumor development. Yet, these same cells can promote cancer growth in a laboratory setting. Until ...

Pancreatic cancer remains one of the most difficult cancers to treat, in large part because tumors do not exist in isolation.

Scientists have discovered how cells decide when to respond to physical forces, potentially opening new avenues for tackling ...

A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.

New study shows that aggressive cancer cells can be identified in a simple, new way; by how they physically behave, not just by their genes. Using specially textured Meta surfaces pattered with tiny ...

What is Keytruda and how does it work? Experts explain the cancer immunotherapy as a global investigation raises concerns ...

A Moffitt Cancer Center researcher has introduced a new model that addresses one of biology's most fundamental questions: How does genetic information keep living systems organized and therefore alive ...

Researchers at NYU Langone Health propose a model that could explain how cancer cells adapt to environmental stress, an approach that may lead to new therapies. Published online April 15 as the cover ...